IL1B and Parkinson disease: To confirm if microglial NLRP3 inflammasome activation plays a key role in our MPTP-induced PD mouse model, we tested the effect of an IL-1 receptor antagonist (IL-1Ra), which prevents inflammasome-driven IL-1β signaling by blocking the IL-1 receptor.